⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4631979 | 0.84 | — | — | |
| SCHEMBL6426976 | 0.78 | — | — | |
| SCHEMBL1979030 | 0.78 | — | — | |
| SCHEMBL1832331 | 0.61 | — | — | |
| SCHEMBL3872112 | 0.54 | — | — | |
| SCHEMBL740559 | 0.54 | — | — | |
| SCHEMBL570870 | 0.47 | — | — | |
| SCHEMBL11337 | 0.45 | — | — | |
| Hydrochloric Acid SCHEMBL3932836 | 0.42 | — | — | |
| Hydrochloric Acid SCHEMBL504814 | 0.42 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2297 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12359120-B2 | Organometallic compound, organic light-emitting device including organometallic compound, and apparatus including organometallic compound | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-07-15 | — | — | US | claimed |
| WO-2024163405-A1 | BORON CONTAINING COMPOUNDS AND THEIR USES | 5METIS, INC. (US) | 2024-08-08 | — | — | WO | claimed |
| CN-112543764-B | Amide compound with BET proteolytic induction effect and medical application thereof | 田边三菱制药株式会社 | 2024-05-10 | — | — | CN | claimed |
| US-11976086-B2 | Organometallic compound, organic light-emitting device including the organometallic compound, and apparatus including the organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-05-07 | — | — | US | claimed |
| EP-3733659-B1 | AROMATIC VINYL OR AROMATIC ETHYL DERIVATIVE, PREPARATION METHOD THEREFOR, INTERMEDIATE, PHARMACEUTICAL COMPOSITION, AND APPLICATION | GUANGZHOU MAXINOVEL PHARMACEUTICALS CO LTD (CN) | 2023-12-20 | — | — | EP | claimed |
| US-RE49687-E1 | Thienopyrimidine and thienopyridine compounds and methods of use thereof | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2023-10-10 | — | — | US | claimed |
| US-11696491-B2 | Organometallic compound, organic light-emitting device including the same and apparatus including the organometallic compound | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-07-04 | — | — | US | claimed |
| US-11542273-B2 | Amide compound having bet proteolysis-inducing action and medicinal application thereof | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2023-01-03 | — | — | US | claimed |
| US-20220315525-A1 | AROMATIC VINYL OR AROMATIC ETHYL DERIVATIVE, PREPARATION METHOD THEREFOR, INTERMEDIATE, PHARMACEUTICAL COMPOSITION, AND APPLICATION | GUANGZHOU MAXINOVEL PHARMACEUTICALS CO., LTD (CN) | 2022-10-06 | — | — | US | claimed |
| CN-112707675-B | Efficient concrete defoaming agent composition and preparation method thereof | 科之杰新材料集团(海南)有限公司 | 2022-09-27 | — | — | CN | claimed |
| US-20030195201-A1 | Vanilloid receptor ligands and their use in treatments | AMGEN INC. | 2003-10-16 | — | — | US | claimed |
| US-20030191115-A1 | Lactam-containing compounds and derivatives thereof as factor Xa inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2003-10-09 | — | — | US | claimed |
| WO-2003049702-A2 | VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS | AMGEN INC. (US) | 2003-06-19 | — | — | WO | claimed |
| WO-2003048158-A1 | GLYCINAMIDES AS FACTOR XA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-06-12 | — | — | WO | claimed |
| WO-2003047520-A2 | SUBSTITUTED AMINO METHYL FACTOR Xa INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-06-12 | — | — | WO | claimed |
| WO-2003048081-A2 | GLYCINAMIDES AS FACTOR XA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-06-12 | — | — | WO | claimed |
| WO-2003026652-A1 | LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-04-03 | — | — | WO | claimed |
| EP-0197876-B1 | THERAPEUTICAL COMPOSITION FOR USE IN DERMATOLOGY CONTAINING IMIDAZOLIDINYL UREA AS AN ACTIVE SUBSTANCE | ANBEN (FR) | 1990-07-11 | — | — | EP | claimed |
| EP-0161361-B1 | MICROBICIDAL COMPOSITIONS CONTAINING HYDROXYPROPYL METHANETHIOLSULFONATE | BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) | 1989-04-05 | — | — | EP | claimed |
| EP-0197876-A1 | Therapeutical composition for use in dermatology containing imidazolidinyl urea as an active substance | ANBEN (FR) | 1986-10-15 | — | — | EP | claimed |